Refine Search

New Search

Result: 1

(searched for: 10.29328/journal.jnnd.1001054)
Save to Scifeed
Page of 1
Articles per Page
by
Show export options
  Select all
Journal of Neuroscience and Neurological Disorders, Volume 5, pp 072-082; https://doi.org/10.29328/journal.jnnd.1001054

Abstract:
Huntington’s disease (HD) is an incurable neurodegenerative disease that causes involuntary movements, emotional lability, and cognitive dysfunction. HD symptoms usually develop between ages 30 and 50, but can appear as early as 2 or as late as 80 years. Currently no neuroprotective and neurorestorative interventions are available. Early multimodal intervention in HD is only possible if the genetic diagnosis is made early. Early intervention in HD is only possible if genetic diagnosis is made at the disease onset or when mild symptoms manifest. Growing evidence and understanding of HD pathomechanism has led researchers to new therapeutic targets. Here, in this article we will talk about the multimodal treatment strategies and recent advances made in this field which can be used to target the HD pathogenesis at its most proximal level.
Page of 1
Articles per Page
by
Show export options
  Select all
Back to Top Top